Curious what do you mean by point 4 in the ASO portion. What would the would a change in FDA trial control requirements for ASOs and run more trials in parallel look like"
Personally, I think ASO cos should take a lesson from precision onc and run basket trials often to test different approaches and segment population.
Curious what do you mean by point 4 in the ASO portion. What would the would a change in FDA trial control requirements for ASOs and run more trials in parallel look like"
Personally, I think ASO cos should take a lesson from precision onc and run basket trials often to test different approaches and segment population.